U10 DA013043/DA/NIDA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	2
2005	2
2006	3
2007	9
2008	8
2009	5
2010	16
2011	20
2012	8
2013	8
2014	9
2015	2
2016	6
2017	3
2018	5
2019	8
2021	2
2024	0

1

Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone.

Zhu Y, Mooney LJ, Yoo C, Evans EA, Kelleghan A, Saxon AJ, Curtis ME, Hser YI. Zhu Y, et al. Drug Alcohol Depend. 2021 Nov 1;228:108996. doi: 10.1016/j.drugalcdep.2021.108996. Epub 2021 Aug 28. Drug Alcohol Depend. 2021. PMID: 34555691 Free PMC article. Clinical Trial.

2

Dental Care Utilization of Hospitalized Persons Living with HIV and Substance Use.

Santella AJ, Parish C, Dan R, Feaster DJ, Rodriguez AE, Del Rio C, Armstrong WS, Jacobs P, Metsch LR. Santella AJ, et al. J Community Health. 2021 Jun;46(3):557-564. doi: 10.1007/s10900-020-00876-y. J Community Health. 2021. PMID: 32761292 Free PMC article.

3

Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder.

Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Evans EA, et al. J Subst Abuse Treat. 2019 Nov;106:19-28. doi: 10.1016/j.jsat.2019.08.002. Epub 2019 Aug 7. J Subst Abuse Treat. 2019. PMID: 31540607 Free PMC article. Clinical Trial.

4

Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV.

Pan Y, Metsch LR, Gooden LK, Philbin MM, Daar ES, Douaihy A, Jacobs P, Del Rio C, Rodriguez AE, Feaster DJ. Pan Y, et al. Int J STD AIDS. 2019 Aug;30(9):891-901. doi: 10.1177/0956462419846726. Epub 2019 Jun 3. Int J STD AIDS. 2019. PMID: 31159715 Free PMC article.

5

Criminal justice outcomes over 5 years after randomization to buprenorphine-naloxone or methadone treatment for opioid use disorder.

Evans EA, Zhu Y, Yoo C, Huang D, Hser YI. Evans EA, et al. Addiction. 2019 Aug;114(8):1396-1404. doi: 10.1111/add.14620. Epub 2019 May 2. Addiction. 2019. PMID: 30916463 Free PMC article. Clinical Trial.

6

Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.

Krupitsky E, Blokhina E, Zvartau E, Verbitskaya E, Lioznov D, Yaroslavtseva T, Palatkin V, Vetrova M, Bushara N, Burakov A, Masalov D, Mamontova O, Langleben D, Poole S, Gross R, Woody G. Krupitsky E, et al. Lancet HIV. 2019 Apr;6(4):e221-e229. doi: 10.1016/S2352-3018(18)30362-X. Epub 2019 Mar 14. Lancet HIV. 2019. PMID: 30880163 Free PMC article. Clinical Trial.

7

Physician Mistrust, Medical System Mistrust, and Perceived Discrimination: Associations with HIV Care Engagement and Viral Load.

Brincks AM, Shiu-Yee K, Metsch LR, Del Rio C, Schwartz RP, Jacobs P, Osorio G, Sorensen JL, Feaster DJ. Brincks AM, et al. AIDS Behav. 2019 Oct;23(10):2859-2869. doi: 10.1007/s10461-019-02464-1. AIDS Behav. 2019. PMID: 30879211 Free PMC article.

8

Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data.

Nijhawan AE, Metsch LR, Zhang S, Feaster DJ, Gooden L, Jain MK, Walker R, Huffaker S, Mugavero MJ, Jacobs P, Armstrong WS, Daar ES, Sullivan M, Del Rio C, Halm EA. Nijhawan AE, et al. J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):330-341. doi: 10.1097/QAI.0000000000001925. J Acquir Immune Defic Syndr. 2019. PMID: 30763292 Free PMC article. Clinical Trial.

9

Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder.

Crist RC, Phillips KA, Furnari MA, Moran LM, Doyle GA, McNicholas LF, Cornish JW, Kampman KM, Preston KL, Berrettini WH. Crist RC, et al. Pharmacogenomics J. 2019 Jun;19(3):260-268. doi: 10.1038/s41397-018-0065-x. Epub 2018 Oct 27. Pharmacogenomics J. 2019. PMID: 30368523 Free PMC article.

10

Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial.

Zhu Y, Evans EA, Mooney LJ, Saxon AJ, Kelleghan A, Yoo C, Hser YI. Zhu Y, et al. J Neuroimmune Pharmacol. 2018 Dec;13(4):488-497. doi: 10.1007/s11481-018-9801-x. Epub 2018 Aug 9. J Neuroimmune Pharmacol. 2018. PMID: 30094695 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year